Startups
Catalyst is a clinical-stage biopharmaceutical company leveraging exceptional science to discover an
Overview
Location
United States, California, South San Francisco
Employees
51-200
Phone
650-871-0761
Total raised
$90M
Founded date
2015
Investors 4
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| May 14, 2021 | EW Healthcare Partners | ewhealthcare.com |
| Avoro Capital | avorocapital.com | |
| Sofinnova Investments | sofinnova.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Dec 4, 2008 | Series C round | $40M |
Mentions in press and media 16
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 27, 2022 | Covid-19 roundup: CDC study shows good protection from mRNA booster plus J&J's single-dose vaccine; White House launches test-to-treat Paxlovid site | Concerns about rare but life-threatening blood clots have limited the use of J&J’s Covid-19 vaccine — once pitched as the only one-shot option in the mix — with the FDA cutting it off except in limited circumstances. Yet t... |
| May 27, 2022 | Transition to new European clinical trials info system starts slowly | Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up... |
| May 27, 2022 | EU reportedly eyeing vaccines deal for monkeypox outbreak; Nasdaq tells Mereo to get stock price up or face delisting | The EU is reportedly working toward a centralized procurement deal for smallpox vaccines to tackle the rising number of cases of monkeypox, according to sources who spoke to the Financial Times. Andrea Ammon, direct... |
| May 27, 2022 | Transition to new European clinical trials info system starts slowly | Catalyst Biosciences was down to five employees in March, and the biotech needed to do something after two rounds of layoffs, a nixed collaboration and a culling of its hemophilia program. In came Vertex, with $60 million to buy up the Sout... |
| May 27, 2022 | Transition to new European clinical trials info system starts slowly | As the close runner-up to Amgen’s Lumakras in the KRAS race, any data cut from Mirati’s adagrasib continues to draw scrutiny from analysts. And the latest batch of numbers from ASCO is a decidedly mixed bag. While a quick comparison suggest... |
| May 26, 2022 | HHS finishes off Trump-era rule that would've erased basic FDA regs without frequent reviews | The Senate is joining its House counterparts and advancing accelerated approval pathway reforms to the FDA user fee legislation that must be signed by President Joe Biden before the end of September or else the FDA will have to start laying... |
| Jan 12, 2022 | Catalyst Biosciences : Investor presentation 5.9 MB | CATALYST BIOSCIENCES Corporate Overview 12 January 2022 Forward looking statements Certain information contained in this presentation and statements made orally during this presentation include forward-looking statements that involve substa... |
| Nov 15, 2021 | Catalyst Biosciences : Investor presentation 4.7 MB | CATALYST BIOSCIENCES Corporate Overview 15 November 2021 © Catalyst Biosciences Forward looking statements Certain information contained in this presentation and statements made orally during this presentation include forward-looking statem... |
| Sep 28, 2021 | Catalyst Biosciences : Investor presentation 3.1 MB | Nasdaq: CBIO CATALYST BIOSCIENCES Corporate Overview 28 September 2021 CatalystBiosciences.com Forward looking statements Certain information contained in this presentation and statements made orally during this presentation include forward... |
Show more
Reviews 0
FAQ about Catalyst Biosciences
When was Catalyst Biosciences founded?
Catalyst Biosciences was founded in 2015.
How much funding has Catalyst Biosciences raised?
Catalyst Biosciences has raised $90M in total across 2 funding rounds.
What funding rounds has Catalyst Biosciences raised?
Parsers VC lists 2 funding rounds of Catalyst Biosciences, among them a Series C round of $40M on Dec 4, 2008.
Who has invested in Catalyst Biosciences?
Parsers VC lists 4 investors of Catalyst Biosciences, among them EW Healthcare Partners, Avoro Capital and Sofinnova Investments.
What has the press written about Catalyst Biosciences?
Parsers VC has collected 16 articles mentioning Catalyst Biosciences, among them “Covid-19 roundup: CDC study shows good protection from mRNA booster plus J&J's single-dose vaccine; White House launches test-to-treat Paxlovid site” (May 27, 2022) and “Transition to new European clinical trials info system starts slowly” (May 27, 2022).
Is Catalyst Biosciences still active?
Yes, Catalyst Biosciences is active; its latest activity on Parsers VC dates from May 27, 2022.